Role of 'catalytic' iron in an animal model of minimal change nephrotic syndrome

Kidney International

Volumn 49, Issue 2, 1996, Pages 370-373

  Ueda, Norishi ^b   Baliga, Radhakrishna ^b   Shah, Sudhir V ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; IRON; PUROMYCIN AMINONUCLEOSIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLOMERULUS; KIDNEY TUBULE; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROTIC SYNDROME; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

EID: 0030052563     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.54     Document Type: Article

References (20)

1. GLASSOCK RJ, ADLER SG, WARD HJ, COHEN AH: Primary glomerular diseases, in The Kidney (4th ed), edited by BRENNER BM, RECTOR FC JR, Philadelphia, WB Saunders Company, 1991, pp 1182-1279
2. PONTICELLI C, PASSERINI P: Treatment of the nephrotic syndrome associated with primary glomerulonephritis. Kidney Int 46:595-604, 1994
3. COUSER WG: Glomerular disorders, in Cecil Textbook of Medicine (19th ed), edited by WYNGAARDEN JB, SMITH LH JR, BENNETT JC, Philadelphia, WB Saunders Company, 1992, pp 551-568
4. HALLIWELL B, GUTTERIDGE JMC: Role of free radicals and catalytic metal ions in human disease: An overview. Meth Enzymol 186:1-85, 1990
5. GUTTERIDGE JMC, CAO W, CHEVION M: Bleomycin-detectable iron in brain tissue. Free Rad Res Commun 11:317-320, 1991
6. GUTTERIDGE JMC, ROWLEY DA, HALLIWELL B: Superoxide-dependent formation of hydroxyl radicals and lipid peroxidation in the presence of iron salts. Biochem J 206:605-609, 1982
7. GUTTERIDGE JMC, ROWLEY DA, HALLIWELL B: Superoxide-dependent formation of hydroxyl radicals in the presence of iron salts. Detection of 'free' iron in biological systems by using bleomycin-dependent degradation of DNA. Biochem J 199:263-265, 1981
8. GUTTERIDGE JMC: Bleomycin-detectable iron in knee-joint synovial fluid from arthritic patients and its relationship to the extracellular antioxidant activities of caeruloplasmin, transferrin and lactoferrin. Biochem J 245:415-421, 1987
9. BALIGA R, UEDA N, SHAH SV: Increase in bleomycin-detectable iron in ischaemia/reperfusion injury to rat kidneys. Biochem J 291:901-905, 1993
10. SHAH SV: Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int 35:1093-1106, 1989
11. LANNIGAN R, KARK R, POLLACK VE: The effect of a single intravenous injection of aminonucleoside of puromycin on the rat kidney: A light-and electron-microscope study. J Pathol Bact 83:357-362, 1962
12. THAKUR V, WALKER PD, SHAH SV: Evidence suggesting a role for hydroxyl radical in puromycin aminonucleoside-induced proteinuria. Kidney Int 34:494-499, 1988
13. UEDA N, GUIDET B, SHAH SV: Measurement of intracellular generation of hydrogen peroxide by rat glomeruli in vitro. Kidney Int 45:788-793, 1994
14. KAWAGUCHI M, YAMADA M, WADA H, OKIGAKI T: Roles of active oxygen species in glomerular epithelial cell injury in vitro caused by puromycin aminonucleoside. Toxicol 72:329-340, 1992
15. ALFREY AC, HAMMOND WS: Renal iron handling in the nephrotic syndrome. Kidney Int 37:1409-1413, 1990
16. OLIVIERI NF, NATHAN DG, MACMILLAN JH, WAYNE AS, LIU PP, MCGEE A, MARTIN M, KOREN G, COHEN AR: Survival in medically treated patients with homozygous β-thalassemia. N Engl J Med 331:574-578, 1994
17. SPEYER JL, GREEN MD, KRAMER E, REY M, SANGER J, WARD C, DUBIN N, FERRANS V, STECY P, ZELENIUCH-JACOUOTTE A, WERNZ J, FEIT F, SLATER W, BLUM R, MUGGIA F: Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer. N Engl J Med 319:745-752, 1988
18. OLIVIERI NF, BRITTENHAM GM, MATSUI D, BERKOVITCH M, BLENDIS LM, CAMERON RG, MCCLELLAND RA, LIU PP, TEMPLETON DM, KOREN G: Iron-chelation therapy with oral deferiprone in patients with thalassemia major. N Engl J Med 332:918-922, 1995
19. HOFFBRAND AV: Prospects for oral iron chelation therapy. J Lab Clin Med 123:492-494, 1994
20. KONTOGHIORGHES GJ, BARR J, NORTEY P, SHEPPARD L: Selection of a new generation for orally active α-ketohydroxypyridine iron chelators intended for use in the treatment of iron overload. Am J Hematol 42:340-349, 1993